Vedanta Biosciences has “significantly reduced” its headcount to channel its remaining resources to its lead live bacteria cocktail program. The company is now “laser-focused” on a phase 3 study of ...

Martha Stewart is practically aging backwards -- so of course we had to give her new skincare a try. marthastewart48/Instagram; Page Six/Hannah Southwick Page Six may ...

Jan 6 (Reuters) - Eli Lilly (LLY.N), opens new tab is in advanced talks to buy Ventyx Biosciences (VTYX.O), opens new tab for more than $1 billion, the Wall Street Journal reported on Tuesday, citing ...

– Collaboration leverages Cartography’s cutting-edge ATLAS and SUMMIT platforms to identify tumor-selective antigens; Pfizer to lead therapeutic development – – Cartography to receive upfront, ...

FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the life science market, today announced the Company has officially changed its legal name from ...

Colossal Biosciences’ new holiday video reimagines a classic Christmas poem with a fluffy, scientific twist Colossal Biosciences debuted a wintry-themed short film starring its woolly mouse ...

SAN DIEGO, Dec. 22, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 3 KINECT®-DCP study evaluating the efficacy, safety, and tolerability of valbenazine ...

Colossal Biosciences is pulling one final surprise out of its hat in 2025. Announced today, the company’s nonprofit arm—The Colossal Foundation—secured an additional $50 million in funding, doubling ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The 75,000-square-foot building ...

Financing co-led by NovaCapital, private high-net-worth individuals and members of Club Degli Investitori BRIDGEWATER, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Juniper Biosciences LLC today announced ...

Solid Biosciences signed a gene therapy agreement with CDMO Andelyn Biosciences for the use of Solid’s proprietary, next-generation capsid, AAV-SLB101. Solid grants Andelyn a non-exclusive worldwide ...

(RTTNews) - Cogent Biosciences (COGT) soared 135.02% to $34.83, up $20.01, after announcing positive clinical data for its investigational treatment bezuclastinib. The trial results showed major ...